Cargando…
Unexpected SARS-CoV-2 cardiorespiratory arrest in a myopathy patient undergoing immunosuppressive treatment: A case report
RATIONALE: It is recommended that patients with Rheumatic diseases that are at high risk of developing active infections be screened for Tuberculosis, Hepatitis B, and Hepatitis C before receiving second-line immunosuppressive therapies. With the emergence 2019 novel coronavirus (SARS-CoV-2), expand...
Autores principales: | DePace, Nicholas L., Soloway, Stephen, Roshal, David, Soloway, Alyxandra Morgan, Colombo, Joe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386952/ https://www.ncbi.nlm.nih.gov/pubmed/32791748 http://dx.doi.org/10.1097/MD.0000000000021377 |
Ejemplares similares
-
Cyanosis With Dysautonomia Mimics Raynaud Disease
por: Soloway, Alyxandra Morgan, et al.
Publicado: (2020) -
Lupus Pneumonitis Therapy Masks Coronavirus (COVID-19)
por: Soloway, S., et al.
Publicado: (2021) -
Hashimoto’s thyroiditis-related myopathy in a patient with SARS-CoV-2 infection: A case report and systematic literature review
por: Lee, Zheng Cong, et al.
Publicado: (2023) -
Humoral immune response against BNT162b2 mRNA COVID-19 vaccine in patients with rheumatic disease undergoing immunosuppressive therapy: A Japanese monocentric study
por: Sugihara, Koichi, et al.
Publicado: (2022) -
Myopathy is a Risk Factor for Poor Prognosis of Patients with Systemic Sclerosis: A retrospective cohort study
por: Zhou, Meiju, et al.
Publicado: (2020)